1. Home
  2. GIG vs FDMT Comparison

GIG vs FDMT Comparison

Compare GIG & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GIG
  • FDMT
  • Stock Information
  • Founded
  • GIG 2024
  • FDMT 2013
  • Country
  • GIG United States
  • FDMT United States
  • Employees
  • GIG N/A
  • FDMT N/A
  • Industry
  • GIG
  • FDMT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GIG
  • FDMT Health Care
  • Exchange
  • GIG NYSE
  • FDMT Nasdaq
  • Market Cap
  • GIG 334.0M
  • FDMT 268.6M
  • IPO Year
  • GIG 2024
  • FDMT 2020
  • Fundamental
  • Price
  • GIG $10.05
  • FDMT $4.67
  • Analyst Decision
  • GIG
  • FDMT Buy
  • Analyst Count
  • GIG 0
  • FDMT 11
  • Target Price
  • GIG N/A
  • FDMT $41.70
  • AVG Volume (30 Days)
  • GIG 10.4K
  • FDMT 1.1M
  • Earning Date
  • GIG 01-01-0001
  • FDMT 02-27-2025
  • Dividend Yield
  • GIG N/A
  • FDMT N/A
  • EPS Growth
  • GIG N/A
  • FDMT N/A
  • EPS
  • GIG N/A
  • FDMT N/A
  • Revenue
  • GIG N/A
  • FDMT $17,000.00
  • Revenue This Year
  • GIG N/A
  • FDMT N/A
  • Revenue Next Year
  • GIG N/A
  • FDMT $159.49
  • P/E Ratio
  • GIG N/A
  • FDMT N/A
  • Revenue Growth
  • GIG N/A
  • FDMT N/A
  • 52 Week Low
  • GIG $9.89
  • FDMT $4.48
  • 52 Week High
  • GIG $10.10
  • FDMT $36.25
  • Technical
  • Relative Strength Index (RSI)
  • GIG N/A
  • FDMT 32.64
  • Support Level
  • GIG N/A
  • FDMT $4.68
  • Resistance Level
  • GIG N/A
  • FDMT $5.15
  • Average True Range (ATR)
  • GIG 0.00
  • FDMT 0.41
  • MACD
  • GIG 0.00
  • FDMT -0.05
  • Stochastic Oscillator
  • GIG 0.00
  • FDMT 8.69

About GIG GIGCAPITAL7 CORP.

GigCapital7 Corp is a Private-to-Public Equity (PPE) company, also known as a blank check company or special purpose acquisition company.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: